Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma F. M. J. DebruyneP. J. J. van MunsterW. J. Kirkels Originals Pages: 233 - 237
Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer J. KanetiY. WinikoffR. Shainkin-Kestenbaum Originals Pages: 239 - 241
Prostatic origin of fucosyl transferase in huma seminal plasma — A study on healthy controls and on men with infertility or with prostatic cancer G. RonquistB. Stegmayr Originals Pages: 243 - 247
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue J. M. AllenG. WilliamsS. R. Bloom Originals Pages: 249 - 251
Determination of the distribution of Zinc and Cadmium in cellular fractions of BPH, normal prostate and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices A. FeustelR. Wennrich Originals Pages: 253 - 256
Rectal temperature monitoring during neodymion-YAG laser irradiation for prostatic carcinoma H. O. BeislandE. Stranden Originals Pages: 257 - 259
Serum beta 2 microglobulin levels in patients with renal cell carcinoma C. SelliF. CozzolinoD. Vercelli Originals Pages: 261 - 263
